London Calling 2024 - Speakers
Speakers
Check out the line up of speaking at London Calling 2024.
Oxford Nanopore Technologies
Dr. Charles K. Cooper
![Charles K Cooper](https://a.storyblok.com/f/196663/400x400/59d0bfd5b9/charles-k-cooper.png/m/350x0/filters:format(webp))
- Job title
- Institution
- bioMérieux, France
- Biography
Dr. Charles K. Cooper is a graduate from Georgetown University School of Medicine (Washington, DC) and specialized in infectious diseases and epidemiology (University of Maryland, Baltimore). He has been practicing medicine for over 25 years and still devotes two days a month to this work.
He was previously Chief Medical Officer at Siemens Healthcare Diagnostics. He also spent eight years as the head of Medical Affairs at Becton Dickinson Diagnostics and 13 years with the U.S. Food & Drug Administration. With this extensive experience in both governmental and private organizations, Dr. Charles K. Cooper is working to address global patients and customers’ needs, helping to improve public health worldwide.
- Recent publications
Pekosz, A. et al. Antigen-based testing but not real-time polymerase chain reaction correlates with severe acute respiratory syndrome coronavirus 2 viral culture. Clin. Infect. Dis. 73(9):e2861–e2866 (2021). doi: 10.1093/cid/ciaa1706.
Parvu, V. et al. Factors that influence the reported sensitivity of rapid antigen testing for SARS-CoV-2. Front. Microbiol. 12:714242 (2021). DOI: 10.3389/fmicb.2021.714242
Shah, M, et al. Multicenter study of the accuracy of the BD MAX multidrug-resistant Tuberculosis assay for detection of Mycobacterium tuberculosis complex and mutations associated With resistance to Rifampin and Isoniazid. Clin. Infect. Dis. 71(5):1161–1167. (2020). DOI: 10.1093/cid/ciz932